Company Overview
Cyera's core product is an AI-native data security platform built around discovery, classification, context, access analysis, and remediation. It inventories structured and unstructured data across cloud, SaaS, data lakes, databases, file shares, and other repositories; identifies sensitive content by meaning and business context; and connects findings to identities, entitlements, usage, and movement. The current platform groups products around DSPM, Omni DLP, Access Trail, AI Guardian/AI-SPM, AI Protect, remediation, privacy, and managed DataWatcher services. The strategic product claim is a unified data-and-access control plane rather than another static scanner.
The customer problem is becoming more urgent as enterprises deploy copilots, conversational systems, and autonomous agents that can reach proprietary data at machine speed. Cyera's value is strongest when security and data-governance teams need to prioritize exposure instead of merely enumerate assets: an organization can identify over-permissioned sensitive stores, investigate which human or non-human identity touched data, detect data leakage in AI or SaaS workflows, and route corrective actions into operational processes. Public customer stories and the company's product materials provide commercialization evidence, but detailed retention, revenue, and independently verified deployment metrics remain diligence items.
Cyera is a late-stage private company in a crowded and consolidating market. Its competition includes standalone DSPM and data-discovery vendors, DLP and insider-risk providers, CNAPP and cloud-security suites, identity/security platforms, and hyperscaler-native controls. The company has expanded rapidly through product development and acquisitions, including Trail Security, Otterize, and the announced Ryft transaction, while adding integrations with major cloud, data, and AI ecosystems. This broadening can improve platform economics and distribution, but it also creates execution risk: buyers will judge whether the combined system produces accurate findings and measurable remediation rather than a larger collection of overlapping modules.
The funding trajectory is a powerful scale signal but not proof of durable economics. Cyera announced a $600 million Series G in June 2026 at a reported $12 billion valuation, following the January 2026 Series F and more than $1.7 billion in previously reported funding. The company reports a global workforce in the low-thousands range through its public LinkedIn profile and maintains headquarters in New York and Tel Aviv. The valuation makes growth quality, gross-margin profile, net retention, implementation time, and integration discipline especially important questions.
The defense and national-security relevance is credible at the infrastructure and information-assurance layer, not as a weapon system. Government and defense organizations face the same data sprawl, over-privileged access, insider-risk, ransomware, and AI-governance problems, often with stricter sovereignty, enclave, logging, and authorization requirements. Cyera's official newsroom says its FedRAMP High authorization is in process; that is a meaningful route toward federal adoption but should not be treated as completed authorization. Actual defense value still depends on deployment in restricted or disconnected environments, support for agency-specific controls, and evidence that classification and remediation work reliably on mission data.
Dual-Use Assessment
Cyera's core data discovery, classification, access analysis, DLP, and AI-governance capabilities apply to both enterprises and government/defense organizations protecting sensitive information. The dual-use case is substantive for cloud and hybrid environments, but restricted-enclave support, procurement eligibility, and completed federal authorization require verification; public evidence currently describes FedRAMP High as in process rather than complete.
Strategic Fit Assessment
Priority signal means this entry may be worth researching within the Claw & Talon thesis. It does not mean investable, suitable, endorsed, available, or likely to produce returns.
Cyera is a credible strategic-priority signal because it operates at the intersection of data security, AI adoption, identity, and cloud control. The Series G and broad product expansion indicate exceptional access to capital and a large enterprise opportunity, while the public customer, ecosystem, and federal-market signals support meaningful commercial traction. This is not an investment recommendation: diligence should focus on net retention, revenue quality, classification accuracy, implementation burden, acquisition integration, competitive displacement, and whether a $12 billion private valuation is supported by durable operating performance.
Strategic Value to U.S.-Israel Alliance
Cyera could provide allied enterprises and public-sector operators with a data-centric control layer for zero-trust and AI modernization. Its ability to connect data meaning, identity, access, movement, and policy can improve insider-risk investigation, ransomware impact analysis, supply-chain data protection, privacy compliance, and safe use of generative or agentic AI. Strategic value is highest where sensitive data is distributed across cloud and SaaS systems; it is lower until the company demonstrates reliable operation in restricted, sovereign, or disconnected environments and converts FedRAMP High from in-process status to an actual authorization.
Key Technologies
- AI-native semantic classification of structured and unstructured sensitive data
- Data Security Posture Management across cloud, SaaS, databases, data lakes, and file shares
- Data Loss Prevention for data in motion and AI application interactions
- Human and non-human identity, entitlement, access-trail, and data-risk correlation
- AI-SPM and agentic-AI usage governance for shadow AI and enterprise agents
- Automated remediation, policy enforcement, workflow integrations, and continuous data-risk monitoring
Use Cases & Applications
- Discovering and prioritizing exposed PII, PHI, PCI, intellectual property, and regulated data across multi-cloud estates
- Investigating which users, service accounts, or AI agents accessed sensitive records and reducing excessive entitlements
- Blocking or auditing sensitive-data leakage through SaaS applications, copilots, chatbots, and enterprise AI agents
- Supporting cloud migration, M&A, incident response, and ransomware blast-radius analysis with data-context evidence
- Continuous data-security and privacy posture monitoring for financial services, healthcare, and other regulated enterprises
- Federal and defense-cloud data inventory, access governance, and AI-readiness assessment where the required deployment and authorization boundaries are met
Sources and verification
This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work; the research methodology documents how evidence is graded, what counts as an independent source, and why some profiles are excluded from search indexing.
This record lists 15 public references used for company identity, status, positioning, or material-claim review.
Public sources
The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.
- Cyera Series G announcement Company announcement of $600 million Series G, valuation and investors.
- Cyera Series G extension coverage Axios reports $400 million Goldman Sachs Alternatives Series G extension.
- Cyera Series F Series F amount and participants.
- Cyera About and leadership Company identity, product framing and executive leadership.
- Cyera launches with $60 million Company launch, financing and Israel/US locations.
- Cyera Series B Series B amount and investors.
- Cyera Series C Series C amount, valuation and investors.
- Cyera Series D Series D terms and investors.
- Cyera Series E Series E, growth, customer and employee claims.
- Cyera Series F coverage Independent reporting on Series F, employees, customers and ARR disclosure.
- Cyera acquires Ryft Company acquisition announcement.
- Cyera FedRAMP High status Company newsroom context; FedRAMP High authorization described as in process in retained analysis; status should be rechecked against current official notice.
- Cyera Series A local coverage Israeli media reporting on $56 million Series A and Israeli team footprint.
- Cyera leadership appointment Company appointment of Brandon Sweeney.
- Official website
- Profile update timestamp Last updated in the Claw & Talon database on Oct 5, 2026.
Investor Lens
What this entry is
Private startup
Why it may matter
Cyera may matter as a Cybersecurity entry with not currently an investable standalone company for Israeli technology research.
How an independent investor should read this
Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.
Evidence to verify
- Verify current status
- Verify traction
- Verify cap table/funding
- Verify technical claims
- Verify regulatory/export-control issues
- Verify customer concentration
Main investor questions
- Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
- What customer, revenue, product, and technical evidence supports the company story?
- What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
- Does the dual-use claim map to actual commercial and government/defense/resilience buyer evidence?
- What evidence would change the thesis or show that the profile is stale?
What not to infer
- Inclusion does not imply endorsement.
- Inclusion does not imply allocation availability or current fundraising.
- Scores do not indicate investment suitability or expected returns.
- Strategic importance does not automatically imply venture return potential.
Diligence questions
- What evidence verifies Cyera's current customer traction, deployment status, and revenue concentration?
- Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
- Where does the product create real defense, intelligence, critical-infrastructure, or emergency-response value beyond ordinary commercial adoption?
- How does the platform integrate into existing SOC, cloud, identity, or compliance workflows without adding operational burden?
- What would disconfirm the priority signal: weak customer references, thin technical differentiation, poor capital efficiency, or limited allied-market access?
Related sector
See the Cybersecurity sector page for market context, related subcategories, and other Israeli companies in this part of the database.